2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid
C23H24F3N3O3 — CID 122444383
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid
2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid (PubChem CID 122444383) has the molecular formula C23H24F3N3O3 and a molecular weight of 447.46 g/mol. Its IUPAC name is 2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid.
Molecular Properties
| Compound Name | 2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid |
|---|---|
| PubChem CID | 122444383 |
| Molecular Formula | C23H24F3N3O3 |
| Molecular Weight | 447.46 g/mol |
| Exact Mass | 447.18 |
| IUPAC Name | 2-tert-butyl-4-[2-[4-(trifluoromethyl)phenyl]-[1,3]oxazolo[5,4-b]pyridin-6-yl]piperidine-1-carboxylic acid |
| SMILES | CC(C)(C)C1CC(c2cnc3oc(-c4ccc(C(F)(F)F)cc4)nc3c2)CCN1C(=O)O |
| InChI | InChI=1S/C23H24F3N3O3/c1-22(2,3)18-11-14(8-9-29(18)21(30)31)15-10-17-20(27-12-15)32-19(28-17)13-4-6-16(7-5-13)23(24,25)26/h4-7,10,12,14,18H,8-9,11H2,1-3H3,(H,30,31) |
| InChIKey | NQFJWMDNJCGGEV-UHFFFAOYSA-N |
| XLogP | 6.18 |
| TPSA | 79.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 447.46 |
| LogP ≤ 5 | 6.18 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122444383 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.